logo

Gene Delivery Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Gene Delivery Systems Market is segmented by Delivery Systems (Viral Gene Delivery Systems, Non-viral Gene Delivery Systems, and Combined Hybrid Delivery Systems), Application, Route of Administration, and Geography

Home Industry Reports Healthcare Gene Delivery Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2 ...

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The gene delivery systems market studied was anticipated to register a CAGR of 7.3%, over the forecast period. The significant factors attributing to the studied market's growth are the rising incidence and prevalence of chronic diseases and the increasing technological advancement in drug delivery.

  • The increasing ongoing research and development in the field of genomics across the world have also been driving the growth of the market studied. Chronic diseases in developing countries are responsible for more fatalities.
  • Some of the leading chronic diseases in developed countries, such as the United States, are cardiovascular diseases, infectious diseases, cancer, diabetes, and others. As per the CDC (Centers for Disease Control and Prevention), six in ten adults in the United States have a chronic disease.
  • As per the statistics, globally, one in three adults has more than two or more chronic diseases, know as multiple chronic conditions. Gene delivery systems can help immensely in improving the human therapeutics used for the disease treatment.
  • All these key factors are expected to boost the growth of gene delivery systems market over the forecast period.

Scope of the Report

Genetic modification can be characterized as integrating genetic material, that is, RNA or DNA, into the system of cellular gene regulation, either to resolve the expression of a defective gene or to modulate cellular functions by expressing the newly integrated gene and for incorporating the gene delivery systems that are used.

By Delivery Systems
Viral Gene Delivery Systems
Adenovirus Systems
Lentiviral Systems
Retroviral Systems
Other Viral Gene Delivery Systems
Non-viral Gene Delivery
Combined Hybrid Delivery Systems
By Application
Oncology
Infectious Diseases
Cardiovascular Disorders
Diabetes
Pulmonary Disorders
Other Applications
By Route of Administration
Oral
Injectable
Nasal
Other Routes of Administration
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Viral Gene Delivery Systems segment is Expected to Hold the Largest Share in the Gene Delivery Systems Market

  • Dominant share is expected to be retained by the viral gene delivery systems, owing to the attributes, such as long-term expression, short term expression, and efficacy of therapeutic genes, and the rising advancement in technology over the last few years, which have opened up many opportunities for growth in the healthcare industry. The increase in the prevalence of chronic diseases, such as cancer and cardiovascular disorders, has also been aiding to the better market growth of gene delivery systems.
  • The growing emphasis on governing and raising awareness about these treatments by the governments in different countries has resulted in the rapid acceptance of these gene delivery systems worldwide. The rising support for R&D, along with the strong market position of major biopharmaceutical market players, has created a better entry passage for new market entrants.
Factual graph.png

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to maintain its supremacy in the overall gene delivery systems market, throughout the forecast period. The factors, such as the rising prevalence of chronic diseases in the region, technological advancement, and the domicile presence of major players in the region, have been driving the growth and responsible for the dominance of the region. The well-established biotechnology, nanotechnology, and pharmaceutical industry, coupled with rising awareness regarding advanced technologies for the treatment of genetic and chronic diseases among the population in this region, are among the key factors ensuring the dominance of the countries of this region.

Viral Gene Delivery Systems

Competitive Landscape

The gene delivery systems market is highly competitive and consists of a few major players. In terms of market share, few of the major players have been dominating the market studied. And some prominent players have been vigorously making collaborations, acquisition, and launching new products with the other companies, in order to consolidate their market positions across the world. Some of the companies, which have been dominating the market studied are Pfizer Inc., Novartis International AG, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Uniqure NV.

consolo.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Chronic Diseases and Lifestyle Disorders

      2. 4.2.2 Technological Advancements in Research by Biopharmaceutical Companies

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Treatment

      2. 4.3.2 Reimbursement Issues

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Delivery Systems

      1. 5.1.1 Viral Gene Delivery Systems

        1. 5.1.1.1 Adenovirus Systems

        2. 5.1.1.2 Lentiviral Systems

        3. 5.1.1.3 Retroviral Systems

        4. 5.1.1.4 Other Viral Gene Delivery Systems

      2. 5.1.2 Non-viral Gene Delivery

      3. 5.1.3 Combined Hybrid Delivery Systems

    2. 5.2 By Application

      1. 5.2.1 Oncology

      2. 5.2.2 Infectious Diseases

      3. 5.2.3 Cardiovascular Disorders

      4. 5.2.4 Diabetes

      5. 5.2.5 Pulmonary Disorders

      6. 5.2.6 Other Applications

    3. 5.3 By Route of Administration

      1. 5.3.1 Oral

      2. 5.3.2 Injectable

      3. 5.3.3 Nasal

      4. 5.3.4 Other Routes of Administration

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East & Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Pfizer Inc.

      2. 6.1.2 Novartis International AG

      3. 6.1.3 F. Hoffmann-La Roche AG

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Uniqure N.V.

      6. 6.1.6 Shenzhen SiBiono GeneTech Co. Ltd

      7. 6.1.7 Bayer AG

      8. 6.1.8 Amgen Inc.

      9. 6.1.9 Shanghai Sunway Biotech Co. Ltd

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Gene Delivery Systems Market market is studied from 2018 - 2026.

The Gene Delivery Systems Market is growing at a CAGR of 7.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Pfizer, Inc., Novartis Internationla AG, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Uniqure N.V. are the major companies operating in Gene Delivery Systems Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!